|
白芍总苷联合盐酸左西替利嗪治疗湿疹临床疗效的Meta分析
|
Abstract:
目的:通过Meta分析评价湿疹患者应用白芍总苷后外周血辅助型T细胞1 (Th1)/辅助型T细胞2 (Th2)水平的变化及临床治疗程度。方法:检索中国知网、万方、维普、Pubmed数据库。检索时限从建库至2023年3月。对检索后的文献进行筛选、质量评估及数据提取。通过Revman5.4软件进行统计分析。结果:本研究共纳入8项研究,总计受试者1260例,分为试验组633例,对照组627例。结果显示,相比于对照组,联合白芍总苷组的外周血Th1/Th2水平,具有统计学差异[MD = 1.20, 95% CI (0.74, 1.65)]。治疗有效率[OR = 2.31, 95% CI (1.72, 3.09)]明显高于对照组(P < 0.05)。治疗后不良反应[OR = 1.73, 95% CI (0.74, 2.30)]未见区别(P > 0.05)。结论:白芍总苷通过平衡湿疹患者血清中Th1/Th2比例,调节机体免疫功能,治疗皮损表现。联合白芍总苷治疗湿疹,治疗效果良好,安全性较高。
Objective: To evaluate the changes of peripheral blood helper T cell 1 (Th1)/helper T cell 2 (Th2) levels and clinical efficacy in patients with eczema treated with total glucosides of paeony (TGP). Methods: The databases of CNKI, Wanfang, VIP and Pubmed were searched from the establishment of the database to March 2023. After screening, data extraction and bias risk assessment of the re-trieved literature, Revman5.4 software was used for statistical analysis. Results: A total of 1260 pa-tients were included in 8 clinical studies, including the experimental group (n = 633) and the con-trol group (n = 627). The results showed that the level of Th1/Th2 in the combination group was significantly higher than that in the control group [MD = 1.20, 95% CI (0.74, 1.65)], and the effective rate of treatment [OR = 2.31, 95% CI (1.72, 3.09)] was better than that in the control group (P < 0.05). There was no significant difference in adverse reactions after treatment [OR = 1.73, 95% CI (0.74, 2.30)], P > 0.05. Conclusion: Total glucosides of paeony can regulate immune and inflamma-tory reaction and improve skin lesions by balancing the proportion of Th1/Th2 in serum of patients with eczema. Combined with total glucosides of paeony, the treatment of eczema has good thera-peutic effect and high safety.
[1] | 李邻峰, 李元文. 中成药治疗湿疹临床应用指南(2020年) [J]. 中国中西医结合杂志, 2021, 41(2): 133-142. |
[2] | Lehman, H. and Gordon, C. (2019) The Skin as a Window into Primary Immune Deficiency Diseases: Atopic Dermatitis and Chronic Mucocutaneous Candidiasis. The Journal of Allergy and Clinical Immunology: In Prac-tice, 7, 788-798.
https://doi.org/10.1016/j.jaip.2018.11.026 |
[3] | Silverberg, J.I., Gelfand, J.M., Margolis, D.J., Boguniewicz, M., Fonacier, L., Grayson, M.H., et al. (2019) Pain Is a Common and Burdensome Symptom of Atopic Dermatitis in United States Adults. The Journal of Allergy and Clinical Immunology: In Practice, 7, 2699-706. https://doi.org/10.1016/j.jaip.2019.05.055 |
[4] | 路雪艳, 李邻峰, 尤艳明. 丽水市社区人群皮肤病流行病学调查及风险因素分析[J]. 中国麻风皮肤病杂志, 2008, 24(9): 692-694. |
[5] | Wollenberg, A., Kinberger, M., Arents, B., et al. (2022) European Guideline (EuroGuiDerm) on Atopic Eczema—Part II: Non-Systemic Treatments and Treatment Recommendations for Special AE Patient Populations. Journal of the European Academy of Dermatology and Venereol-ogy, 36, 1904-1926. https://doi.org/10.1111/jdv.18429 |
[6] | 顾礼忠, 吕宁, 马立娟. 外用钙调磷酸酶抑制剂治疗皮肤病的应用现状[J]. 世界临床药物, 2014, 35(3): 178-183. |
[7] | 杨赛琳, 许爱娥. 钙调磷酸酶抑制剂他克莫司、吡美莫司在特应性皮炎外的皮肤科应用[J]. 中国中西医结合皮肤性病学杂志, 2018, 17(1): 91-94. |
[8] | 孙志高, 路军章, 周杉京, 樊金灼, 许成勇. 中医药治疗湿疹的研究进展[J]. 中华中医药杂志, 2017, 32(8): 3617-3619. |
[9] | 曹泽敏, 邓平. 盐酸左西替利嗪片联合白芍总苷胶囊治疗湿疹效果分析[J]. 深圳中西医结合杂志, 2021, 31(13): 28-29. |
[10] | 苏燕晨. 左西替利嗪片联合白芍总苷胶囊对皮炎湿疹的作用[J]. 中国城乡企业卫生, 2019, 34(12): 173-174. |
[11] | 孙国强, 王宏蕾, 郑树茂. 盐酸左西替利嗪片联合白芍总苷胶囊治疗皮炎湿疹的临床疗效[J]. 中华中医药学刊, 2017, 35(11): 2915-2917. |
[12] | 吴冬梅. 盐酸左西替利嗪片联合白芍总苷胶囊治疗皮炎湿疹的临床观察[J]. 实用药物与临床, 2013, 16(1): 67-68. |
[13] | 张丽萍, 江萍. 白芍总苷联合盐酸左西替利嗪治疗皮炎湿疹临床观察[J]. 中国药业, 2020, 29(8): 126-128. |
[14] | 王建东, 黄和文, 叶俊华. 联合应用白芍总苷胶囊和盐酸左西替利嗪片治疗皮炎、湿疹的临床疗效观察[J]. 当代医药论丛, 2014, 12(18): 183-184. |
[15] | 陶艳霞, 何金. 盐酸左西替利嗪片联合白芍总苷胶囊治疗皮炎湿疹的疗效[J]. 中医临床研究, 2019, 11(18): 70-71. |
[16] | 杨长志, 钱齐宏, 朱婷婷, 余秀琴. 白芍总苷胶囊联合盐酸左西替利嗪片治疗皮炎湿疹的临床观察[J]. 临床和实验医学杂志, 2012, 11(9): 701-702. |
[17] | 叶萍, 黄伟林, 郑力, 王晓川. 复方甘草酸苷辅助左西替利嗪治疗慢性湿疹43例[J]. 中国药业, 2010, 19(5): 54-55. |
[18] | 王修勇, 常远, 高明, 张帆. 湿疹病情与患者血清Th1/Th2细胞因子的关系研究[J]. 医学理论与实践, 2021, 34(12): 2086-2088. |
[19] | 许文, 冯爱民, 周红, 万钧. 糠酸莫米松乳膏联合卡泊三醇软膏治疗慢性湿疹及神经性皮炎的效果[J]. 广东医学, 2015, 36(1): 130-132. |
[20] | van Elten, T.M., van Rossem, L., Wijga, A.H., et al. (2015) Breast Milk Fatty Acid Composition Has a Long-Term Effect on the Risk of Asthma, Eczema, and Sensitization. Allergy, 70, 1468-1476. https://doi.org/10.1111/all.12703 |